Last week, the first official guidance on medical cannabis for police officers in England and Wales was made public. Its publication marks a significant step forward for both the patient community and law enforcement, finally providing an initial standardised set of principles for both to adhere [...]
Over seven years after medical cannabis was legalised in the UK, the National Police Chiefs’ Council has approved the first official guidance for medical cannabis. The guidance, titled ‘Medicinal Cannabis and the Police – Guidance for Officers and Staff’, crucially calls for officers in England and [...]
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it really [...]
From tighter telemedicine rules to evolving product frameworks, as global medical cannabis markets mature, many are entering a more cautious phase as we head into 2026. After a broadly optimistic and reform-driven 2024, this year saw momentum begin to shift once again for the global medical [...]
Dr Simon Erridge, Head of Research, Curaleaf Clinic, reflects on some of the key findings published from the UK Medical Cannabis Patient Registry this year. As we look back on 2025, it’s been another year of deepening understanding about how medical cannabis is being used in [...]
A team of scientists testing the effects of CBD and THC on ovarian cancer cells have found that both show promising anti-cancer effects. While still in the early stages, researchers say these preliminary findings from the laboratory present an important opportunity to develop effective new therapies [...]
Chancellor Rachel Reeve’s recent budget announcement is yet to be fully digested, and the implications for UK businesses and the wider public are still being analysed. However, one thing remains clear: growth is the priority. As we heard repeatedly at this week’s Cannabis Health Symposium, the [...]
As a new review highlights significant gaps in the evidence base for medical cannabis, researchers have called for more rigorous studies and access to “balanced information” to support healthcare professionals and their patients. The authors of a new comprehensive review have concluded that medical cannabis lacks [...]
UK cannabinoid-based medicines manufacturer, 113 Botanicals, is raising £2 million to help launch its first controlled-release capsule, designed to improve dosing consistency and expand options for patients and prescribers. Working in partnership with scientists at the University of Sussex since 2020, the company is developing new [...]
Adults with chronic pain who participated in New York State’s (NYS) Medical Cannabis Program were significantly less likely to require prescription opioids, according to a new study. The study, published in JAMA Internal Medicine and led by researchers at Albert Einstein College of Medicine and Montefiore [...]
A new paper adds to growing calls for urgent improvements in police training on how to respond to patients prescribed cannabis-based medicines. The research explores how regulations introduced in 2018, making it legal for specialists to prescribe medical cannabis, have not been ‘consistently implemented’, or ‘adequately [...]
The Medical Cannabis Clinicians Society (MCCS) has released a landmark guide setting out standardised dosing protocols for cannabis oils, in what the organisation describes as a major step forward for safe, consistent prescribing across the UK. The publication, which officially launched at the Cannabis Health Symposium [...]
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the UK. These in-depth talks spanned everything from pharmacy standards and product quality to the specific challenges [...]
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium. The event embodied the UK medical cannabis industry’s collective drive to push beyond its own barriers and reach out to the wider medical community [...]
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it really [...]
Medical Cannabis Awareness Week has expanded for 2025, with an entire month of momentum-building events and educational initiatives, as organisations in the sector mark seven years since the law change. Over the last few years, Medical Cannabis Awareness Week has become an important date in the [...]
Seven years after medical cannabis was legalised in the UK, new data from Releaf sheds light on how the treatment is changing patients’ lives, but also where progress is still needed. This month, Releaf Cannabis Clinic published one of the most comprehensive surveys of UK medical [...]
Medical cannabis patients made history with a patient-led educational event about cannabis-based medicines, held at the Charterhouse in London. The international patient-led organisation We, The Patients, brought its educational event series to London for the first time on Friday 7 November, in partnership with PatientsCann UK, [...]
Curaleaf Laboratories, one of the UK’s leading providers of medicinal cannabis products, is pleased to announce a landmark partnership with Australian Natural Therapeutics Group (ANTG), one of Australia’s most respected producers of pharmaceutical-grade medicinal cannabis. Under this agreement, Curaleaf Laboratories will manufacture and distribute ANTG’s range of [...]
In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it [...]
A large UK study suggests that people who use cannabis to self-medicate for pain or anxiety may be more likely to experience paranoia, prompting calls for improved patient monitoring in private prescribing. Researchers from King’s College London recently published the first findings from the Cannabis & [...]
From endometriosis and chronic pelvic pain to PMDD and menopause, more women are turning to cannabis-based medicine, but what do we know and where do we still need more research? In the face of long NHS waiting lists and a lack of options in mainstream healthcare, [...]
Families have marked the seventh anniversary of the legalisation of medical cannabis in the UK with further calls for urgent government action on NHS access. Dozens of families attended Westminster on Tuesday (4 November) to meet with cross-party MPs and demand immediate action to address the [...]
The endocannabinoid system (ECS) helps regulate vital bodily functions from mood and pain to immune response, yet it remains one of medicine’s best-kept secrets. We unpack the science behind the ECS and its significance in a range of chronic conditions. The endocannabinoid system (ECS) plays a [...]
Zurich’s flagship adult-use cannabis trial, Züri Can, could now run until 2028 after city officials applied this week to extend the project by two years, citing strong early results in reducing illicit sales and promoting safer consumption. The move comes as the Swiss Federal Government continues [...]
Healthcare professionals attending the Cannabis Health Symposium next month will be able to earn CPD points to support their professional development. The Cannabis Health Symposium is a Continuing Professional Development (CPD)-accredited event, meaning attendees can earn professional development credits as a result of their participation. The [...]
In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it [...]
Almost seven years since medical cannabis was legalised in the UK on 1st November 2018, less than 1% of the UK’s approximate 100,000 doctors on the General Medical Council (GMC) Specialist Register have the training required to prescribe medical cannabis. While the UK’s medical cannabis market [...]
A growing number of patients are now prescribed medical cannabis for common mental health issues and neurodiverse conditions, such as autism and ADHD. Ahead of Cannabis Health Symposium next month, we examine the research and real-world evidence behind the use of cannabis-based medicines in psychiatry. Many [...]
Curaleaf Laboratories has been confirmed as headline sponsor of the inaugural Cannabis Health Symposium, taking place on 25 November 2025 at Conway Hall, London. The event, delivered in partnership with the Medical Cannabis Clinicians Society (MCCS), will focus on strengthening clinical understanding and confidence in prescribing [...]
The Advisory Council on the Misuse of Drugs (ACMD) has closed its latest call for evidence into the impact of medical cannabis legalisation, in what will mark the most comprehensive review of the UK’s cannabis-based products for medicinal use (CBPM) framework since it was introduced in [...]
How one oncologist is helping redefine patient care and the future of integrated healthcare. Medical cannabis is starting to have a very different kind of conversation in the UK. From mainstream voices like Rory Cellan-Jones exploring patient experiences on his Movers & Shakers podcast, to growing [...]
German pharmaceutical company Vertanical believes it is on course to deliver the first ‘whole-plant’, cannabis medicine with international approval. After seven years of endeavour, and an investment of over $250m, its VER-01 chronic pain-relief drug has passed a Phase 3 trial in its home market. As [...]
As the prevalence of dementia and other neurodegenerative conditions continues to rise globally, there is growing interest in the role of cannabis-based medicines in symptom management. A small number of studies, combined with real-world clinical experience is beginning to provide important insights into the potential of [...]
Medical cannabis patients will host a major educational event in the UK next month, aiming to bridge the gap between patients and healthcare professionals through evidence, empathy and lived experience. The international patient-led organisation We, The Patients, will bring its educational series to London next month [...]
Experts say real-world evidence could offer crucial insights into how these medicines work in practice, and help widen access for patients. For the last 50 years, randomised controlled trials (RCTs) have been considered the ‘gold standard’ research methodology for measuring the safety and efficacy of new [...]
In a historic move, Spain’s Council of Ministers has approved a long-awaited Royal Decree regulating the medicinal use of cannabis preparations in hospital settings. Following years of advocacy on behalf of patients and campaigners, the decision marks a decisive step toward the integration of medical cannabis [...]
Germany’s booming cannabis market, which Prohibition Partners now estimates to be worth around €670m, is entering uncertain and potentially treacherous territory. As the landmark CanG Act approaches its second year, it has become a highly charged and increasingly divisive issue politically, culturally, and medically. With the [...]
Dr Sue Clenton, Medical Director of Releaf cannabis clinic explains what it takes to go from a few hundred to thousands of patients, without compromising on the quality of care. When people talk about growth in healthcare, the conversation often centres on numbers – the number [...]
New guidelines around THC levels, dosages, and eligibility, aim to bring more clarity and consistency to the practice of prescribing cannabis-based medicines in the UK. Almost seven years since medical cannabis was legalised in the UK, around 180 specialist consultants are now actively prescribing. But almost [...]
Words by Lawrence Purkiss and Sarah Sinclair Portugal hosted its seventh international conference on medical cannabis (PTMC) in central Lisbon last week, amid a growing feeling that the country – a once-thriving hub for European cannabis exports – is at an inflection point. Discussion among speakers [...]
By Rupa Shah, Head of Compliance at Releaf The conversation around workers’ rights and medical cannabis is still at a very early stage in the UK. Despite the fact that thousands of patients now access cannabis-based medicines legally through prescription, the framework remains poorly understood by [...]
Mental health advocate and one half of music duo Rizzle Kicks, Jordan Stephens, is collaborating with medical cannabis clinic, Alternaleaf, to shed light on the role of alternative treatments in supporting mental wellbeing. Stephens, who is currently touring with Rizzle Kicks as part of their comeback [...]
The UK’s medical cannabis industry is now the second largest in Europe, second only to Germany, thanks to consistent and sustained growth over the last seven years. While this has seen thousands of new patients gain access to medical cannabis, it still represents just a fraction [...]
A Yorkshire man, who supplied cannabis products to thousands of people with chronic illnesses, has been jailed for four years after his original suspended sentence was overturned. Joel Cunningham, 40, from Leeds, was convicted of seven offences, including possession with intent to supply magic mushrooms and [...]
Cannabis Health has partnered with leading experts at the Medical Cannabis Clinicians Society (MCCS) to bring its first educational event for healthcare professionals to the UK later this year. The Cannabis Health Symposium, taking place at Conway Hall in London on 25 November, 2025, will welcome [...]
New analysis has found that NHS access to medical cannabis could boost the UK’s economy by £13.3 billion over the next decade by returning thousands back to work. Widening NHS access to medical cannabis could add £4.5 billion to the economy over five years, and £13.3 [...]
A major new study, analysing data from over four million adults in the US and Europe, has linked cannabis use to an almost quadrupling in the risk of developing type 2 diabetes. Cannabis use is increasing globally with an estimated 219 million users (4.3% of the [...]
Two new studies, one a large meta-analysis and the other real-world evidence from the UK, suggest that cannabis-based medicines, particularly those containing THC or mixed cannabinoids, may improve sleep quality and ease symptoms of insomnia. A new systematic review and meta-analysis, published in the journal Sleep [...]
The UK’s long-running project to regulate CBD (cannabidiol) products has taken another major step forward, seeing thousands of products make it to the final phase of the novel foods approval process. Yesterday, the Food Standards Agency (FSA) announced that its 12-week public consultation to discuss the [...]
Copyright © 2020 – 2025 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
